LINEAGE CELL THERAPEUTICS IN
LCTX·53566P109·US·Common Stock·Healthcare - Biotechnology-Activist
LCTX (LINEAGE CELL THERAPEUTICS IN) is held by 71 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($13.1M), MILLENNIUM MANAGEMENT LLC ($8.8M), FIFTH THIRD BANCORP ($7.3M). Net institutional sentiment: Mixed.
71
Holders
(7 Elite)
$69.4M
Total Value
65% (65)
Consensus
42 buying - 23 selling
13F: Insider & Congress:
Who's Trading
InsiderCMCulley Brian MBuy $24KMar 12, 2026
ActivistBRBROADWOOD PARTNERS, L.P.23.0%Nov 14, 2025
ActivistCJChernett Jorey5.0%Sep 26, 2025
Top Holders
Showing 1-20 of 74
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer